Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24
United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bassil I Dahiyat
President & CEO
—
—
—
546,316
$7.13M
+54.2%
John R Desjarlais
Sr. Vice President & CSO
—
—
—
263,831
$3.45M
+31.8%
Celia Eckert
SVP, General Counsel
—
—
—
76,918
$1.00M
+58.5%
Bart Jan Cornelissen
Sr. Vice President & CFO
—
—
—
75,898
$991.23K
+71.5%
Nancy Valente
EVP, Chief Development Officer
—
—
—
49,169
$642.15K
−12.7%
Barbara Klencke
Director
—
—
—
29,974
$391.46K
+400.7%
Alan Bruce Montgomery
Director
—
—
—
25,849
$337.59K
+182.8%
Kurt A Gustafson
Director
—
—
—
25,011
$326.64K
+163.6%
Richard J Ranieri
Director
—
—
—
24,011
$313.58K
+182.8%
Todd E Simpson
Director
—
—
—
23,988
$313.28K
—
Kevin Charles Gorman
Director
—
—
—
21,680
$283.14K
+158.3%
Ellen Feigal
Director
—
—
—
12,340
$161.16K
—
Raymond Joseph Deshaies
Director
—
—
—
10,302
$134.54K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.